NON-SMALL CELL LUNG CANCER STAGE IIIA side effect
What is NON-SMALL CELL LUNG CANCER STAGE IIIA ?
Help Community - Describe Your Side Effect
Search FDA Side Effects
Ask Health Expert
NON-SMALL CELL LUNG CANCER STAGE IIIA and Recently Reported Side Effects
NON-SMALL CELL LUNG CANCER STAGE IIIA and 15 most Active Side Effect polls
NON-SMALL CELL LUNG CANCER STAGE IIIA and featured health surveys
Substances toxic to Health
Recent Hospital reviews
Comments about Side Effects
Hospital Quality reviews
Homecare Quality reviews
Drugs associated with NON-SMALL CELL LUNG CANCER STAGE IIIA
REBIFRebif Side Effects Report #5509429-1
Physician from UNITED STATES reported REBIF problem on Oct 22, 2007. Male patient, 70 years of age, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: metastases to lymph nodes, non-small cell lung cancer stage iiia, skin ulcer, . REBIF dosage: unknown. During the same period patient was treated with GLUCOPHAGE ER, PLAVIX, PENTOXIFYLLIN, AMARYL, NEXIUM, ZETIA, FLOMAX, PROPO. Patient recovered.